Travel Medicine and Infectious Disease
Volume 8, Issue 4 , Pages 251-256 , July 2010

Tick borne encephalitis TBE – Vaccination in non-endemic countries

Received 6 May 2010 ,Accepted 13 May 2010.

References 

  1. Banzhoff A, Broker M, Zent O. Protection against tick-borne encephalitis (TBE) for people living in and travelling to TBE-endemic areas. Travel Medicine Infectious Disease. 2008 Nov;6(6):331–341
  2. Haglund M. Occurrence of TBE in areas previously considered being non-endemic: Scandinavian data generate an international study by the International Scientific Working Group for TBE (ISW-TBE). Int J Med Microbiol. 2002 Jun;291(Suppl. 33):50–54
  3. Skarpaas T, Ljostad U, Sundoy A. First human cases of tickborne encephalitis, Norway. Emerg Infect Dis. 2004 Dec;10(12):2241–2243
  4. de Valliere S, Cometta A, Zimmermann H, Vaudaux B, Meylan P. [Evidence of new foci of tick-borne encephalitis in the French speaking part of Switzerland]. 2189 Rev Medicale Suisse. 2006 Sep 27;2(80):91–94
  5. Kunze U. Tick-borne encephalitis: from epidemiology to vaccination recommendations in 2007. New issues–best practices. 1946 Wien Med Wochenschr. 2007;157(9–10):228–232
  6. Rendi-Wagner P. Risk and prevention of tick-borne encephalitis in travelers. J Travel Med. 2004 Sep–Oct;11(5):307–312
  7. Süss J. Tick-borne encephalitis in Europe and beyond–the epidemiological situation as of 2007. Euro Surveill. 2008 Jun 26;13(26):
  8. Fisher M, Griggs A, Staples JE. http.//cdc.gov//travel/yellowbook/2010/chapter-5/tick-borne-encephalitis.aspx
  9. Holzmann H. Diagnosis of tick-borne encephalitis. Vaccine. 2003 Apr 1;21(Suppl. 1):S36–S40
  10. Sumilo D, Asokliene L, Bormane A, Vasilenko V, Golovljova I, Randolph SE. Climate change cannot explain the upsurge of tick-borne encephalitis in the Baltics. PloS One. 2007;2(6):e500
  11. Randolph SE. Evidence that climate change has caused ‘emergence’ of tick-borne diseases in Europe?. Int J Med Microbiol. 2004 Apr;293(Suppl. 37):5–15
  12. Heinz FX, Holzmann H, Essl A, Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine. 2007 Oct 23;25(43):7559–7567
  13. Daniel M, Materna J, Honig V, Metelka L, Danielova V, Harcarik J, et al. Vertical distribution of the tick Ixodes ricinus and tick-borne pathogens in the northern Moravian mountains correlated with climate warming (Jeseniky Mts., Czech Republic). Cent Eur J Public Health. 2009 Sep;17(3):139–145
  14. Pavlidou V, Geroy S, Diza E, Antoniadis A, Papa A. Winter Epidemiological study of tick-borne encephalitis virus in northern Greece. Vector borne and zoonotic diseases (Larchmont, NY). 2007;7(4):611–615
  15. Skarpaas T, Golovljova I, Vene S, Ljostad U, Sjursen H, Plyusnin A, et al. Tickborne encephalitis virus, Norway and Denmark. Emerg Infect Dis. 2006 Jul;12(7):1136–1138
  16. Kim SY, Yun SM, Han MG, Lee IY, Lee NY, Jeong YE, et al. Spring Isolation of tick-borne encephalitis viruses from wild rodents, South Korea. Vector borne and zoonotic diseases (Larchmont, NY). 2008;8(1):7–13
  17. Walder G, Lkhamsuren E, Shagdar A, Bataa J, Batmunkh T, Orth D, et al. Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia. Int J Med Microbiol. 2006 May;296(Suppl. 40):69–75
  18. Ekdahl K, Steffens I. Eurosurveillance moves on. Euro Surveill. 2008 Jan 3;13(1):
  19. Schneider H. Über epidemische akute “Meningitis serosa”. Wien.KLin. Wochenschrift. 1931;44:350–352
  20. Verlinde JD, Van Tongeren HA, Pattyn SR, Rosenzweig A. Virus meningo-encephalitis in Austria. III. Pathogenic and immunological properties of the virus. Bull World Health Organ. 1955;12(4):565–579
  21. Moritsch H, Krausler J. [Endemic spring-summer meningoencephalomyelitis in the Viennese area (Schneider’s disease).]. Wien Klin Wochenschr. 1957 Dec 20;69(51):965–970[concl]
  22. Ecker M, Allison SL, Meixner T, Heinz FX. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol. 1999 Jan;80(Pt 1):179–185
  23. Klockmann U, Krivanec K, Stephenson JR, Hilfenhaus J. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine. Vaccine. 1991 Mar;9(3):210–212
  24. Kunz C. TBE vaccination and the Austrian experience. Vaccine. 2003 Apr 1;21(Suppl. 1):S50–S55
  25. Marth E, Kleinhappl B. Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination. Vaccine. 2001 Nov 12;20(3–4):532–537
  26. Rendi-Wagner P, Kundi M, Zent O, Dvorak G, Jaehnig P, Holzmann H, et al. Persistence of protective immunity following vaccination against tick-borne encephalitis–longer than expected?. Vaccine. 2004 Jul 29;22(21–22):2743–2749
  27. Baumhackl U, Franta C, Retzl J, Salomonowitz E, Eder G. A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis. Vaccine. 2003 Apr 1;21(Suppl. 1):S56–S61
  28. Popov OV, Sumarokov AA, Shkol′nik R, El′bert LB, Vorob′eva MS. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis]. Zh Mikrobiol Epidemiol Immunobiol. 1985 Jun;(6):34–39
  29. Rendi-Wagner P. Advances in vaccination against tick-borne encephalitis. Expert Rev Vaccines. 2008 Jul;7(5):589–596
  30. Kunze U. Conference report of the 9th meeting of the International Scientific Working Group of Tick Borne encephalitis (ISW TBE). Tick borne encephalitis: from epidemiology to current vaccination recommendations. Vaccine. 2007 Dec 5;25(50):8350–8351

PII: S1477-8939(10)00072-4

doi: 10.1016/j.tmaid.2010.05.007

Travel Medicine and Infectious Disease
Volume 8, Issue 4 , Pages 251-256 , July 2010

Article Tools

* Image Usage & Resolution